Search For "ph"
Equity gauges volatile, pharma and FMCG scrips gain
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], May 14 (ANI): Equity benchmark indices swung between gains and losses during early hours on Friday with pharma and FMCG stocks showing gains.
Read More
'Lancet report on India COVID-19 response another attempt to undermine dev
Updated : 5 years, 1 month ago IST
Brussels [Belgium], May 13 (ANI): Medical journal Lancet's latest report on COVID-19 situation in India that discusses the Indian government's management of the pandemic is yet another attempt by the big pharma lobby to undermine the "abilities of a developing country to challenge their mono
Read More
TVS Motor Company signals next phase of Norton Revitalisation with the app
Updated : 5 years, 1 month ago IST
London [United Kingdom] May 13 (ANI/NewsVoir): TVS Motor Company (TVS), owner of The Norton Motorcycle Co. Ltd. (Norton), is announcing the appointment of Dr. Robert Hentschel as Chief Executive Officer (CEO) and Vittorio Urciuoli as Chief Technical Officer (CTO) of the historic Solihull - b
Read More
Lupin Q4 PAT up 18 pc at Rs 460 crore on lower input costs
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], May 13 (ANI): Pharma major Lupin Ltd on Thursday reported 18 per cent jump in its consolidated profit after tax to Rs 460 crore.
Read More
Tech transfer, voluntary licenses to improve vaccine supply: FICCI
Updated : 5 years, 1 month ago IST
New Delhi [India], May 13 (ANI): Industry body FICCI said on Thursday the government should focus on connecting with global pharmaceutical companies to facilitate technology transfer and voluntary licenses to Indian companies which have the capacity and capability for mass production of Covi
Read More
DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to
Updated : 5 years, 1 month ago IST
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.
Read More
Lilly signs 3 more pacts to accelerate availability of baricitinib for Cov
Updated : 5 years, 1 month ago IST
New Delhi [India], May 13 (ANI): Eli Lilly and Company said on Thursday it has issued additional royalty-free, non-exclusive voluntary licenses to Dr Reddy's Ltd, MSN Laboratories and Torrent Pharmaceuticals who will collaborate to accelerate and expand the availability of baricitinib in Ind
Read More
Pharmaceutical market reports strong growth in April: Ind-Ra
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], May 12 (ANI): India Ratings and Research (Ind-Ra) has said the 51.5 per cent year-on-year growth in India's pharmaceutical market during April was led by a low base effect as the market declined by 10.2 per cent in April 2020 due to Covid-19 lockdown.
Read More
Subject Expert Committee gives nod to Covaxin for Phase 2, 3 trials on chi
Updated : 5 years, 1 month ago IST
New Delhi [India], May 12 (ANI): The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eight years old, sources confirmed on Wednesday.
Read More
Zydus Cadila to sell one animal health business for Rs 2,921 crore
Updated : 5 years, 1 month ago IST
Ahmedabad (Gujarat) [India], May 12 (ANI): Pharmaceutical major Zydus Cadila said on Wednesday it has signed agreements to sell one of its animal health business companies to Multiples Alternate Asset Management led consortium for Rs 2,921 crore.
Read More
Sensex jumps 296 points, pharma stocks surge
Updated : 5 years, 1 month ago IST
Mumbai (Maharashtra) [India], May 10 (ANI): Equity benchmark indices were range-bound on Monday but closed in the green on the back of RBI's liquidity measures and indications of robust corporate earnings.
Read More
Lilly signs pacts with Cipla, Lupin, Sun Pharma to accelerate availability
Updated : 5 years, 1 month ago IST
New Delhi [India], May 10 (ANI): US pharmaceutical major Eli Lilly said on Monday it has issued royalty-free, non-exclusive voluntary licenses to Cipla, Lupin and Sun Pharmaceutical to accelerate and expand the availability of baricitinib in India for Covid-19 patients.
Read More